Introduction 50
Despite the strict legislative measures on the use of Penta-BDE and Octa-BDE formulations 51 in both the EU and USA in consumer products (e.g. carpets, electronic appliances and human health concerns remain a critical issue, given the well-known PBDE potential to 59 induce endocrine and thyroid disruption (Legler, 2008) and neurodevelopmental disorders in 60 children (Bellinger, 2013; Costa and Giordano, 2007) .
61
Total pollutant concentration of a contaminated solid matrix is perceived as the bioavailable 62 fraction after ingestion and it is frequently used in human risk and exposure assessment 63 (Semple et al., 2004) . However, the assumption that 100% of the ingested toxicant within a 64 matrix being available is unrealistic (Collins et al., 2015) . Animal bioavailability studies (e.g. 
92
A colon-extended PBET system (CE-PBET) with a carbohydrate-rich colon compartment as sink with large surface area and high sorption capacity for HOCs and was thus used as an
103
"infinite" sink in PBET systems, studying the uptake of FRs and PAHs via indoor dust (Fang 104 and Stapleton, 2014) and soil (Li et al., 2015) small intestine incubation continued as above for 4h (Fig 1 B) colon medium were added and sealed with the metallic clips as described for the stomach 228 compartment, re-introduced into the bottle where the indoor dust was re-suspended using the 229 colon medium and incubated for 16 h (Fig 1C) . At the end of the colon incubation, the dust BDE153, 154 and 184 quantifications, respectively) and shaken on an orbital shaker for 1h.
250
Gut fluids were subjected to a LLE using 30 mL hexane/ethyl acetate 3:1 v/v twice ( (Fig. SI 2 -step 4) . Briefly, Florisil ® cartridges were pre-cleaned with 10 mL ethyl 264 acetate and 6 mL of hexane; our target analytes were eluted using 20 mL hexane. This eluate
265
was further concentrated to 1mL (in hexane) and then subjected to SPE clean-up on 5%
266
acidified silica (5% AS) (2 g, 6 mL). The 5% AS cartridges were pre-cleaned with 6 mL 267 hexane and 3 mL dichloromethane and then all extracts from the Florisil ® step were loaded 268 onto the SPE silica column. Our target analytes were eluted using 16 mL hexane and 8 mL 
318
Despite the moderately lower extraction efficiency for BDE100 in comparison to the other 319 target analytes, the relative standard deviation (RSD%) of the method for BDE100 was 6%.
320
Given the low deviation and variability, no correction was performed for BDE100 (Table SI   321 3). Glass test tubes were cleaned by soaking for at least 12 h in an alkali solution. After 322 washing, the tubes were rinsed with water and dried at 100 ºC for at least 12 h and burnt at
323
400°C to remove all traces of contamination. Given the a) high sorption capacity of Tenax TA ® , b) the broad range of physical properties
373
(MW, water solubility and log Kow) of our FRs mobilised from the ingested matrix and c) the 374 relatively high Tenax TA ® mass recovery ( SI Fig 3) , 0. to the small intestine and colon compartments (Table SI 3 
Method performance using SRM 2585

421
The selected CE-PBET parameters as well as the overall performance of our new method
422
were assessed using SRM 2585 serving as a well-characterised and homogenous dust sample. conditions using SRM 2585 as the same homogenous dust sample. As observed for BAF% 427 using a dust sample from Reading (section 3.1), statistically significant differences (p=0.03)
428
were found in %BAF% for all target analytes when comparing CE-PBET without Tenax TA ® 429 addition (Fig. 4 A) and with Tenax TA ® addition (Fig 4 B & C) . The BAF% when Tenax as BDE28 and BDE47 (nearly 3-fold bioaccessibility increases, respectively) (Fig. 4 B & C the same dust matrix (Fig. 4 B & C) . Finally, compared to the control treatments (i.e. no
437
Tenax TA inclusion), the performance of the novel CE-PBET method described here using 
